Pubblicazioni

Autori:

Gargiulo, L.; Ibba, L.; Malagoli, P.; Amoruso, F.; Balato, A.; Bardazzi, F.; Burlando, M.; Carrera, C. G.; Dapavo, P.; Dini, V.; Gaiani, F. M.; Girolomoni, G.; Guarneri, C.; Lasagni, C.; Loconsole, F.; Marzano, A. V.; Maurelli, M.; Megna, M.; Travaglini, M.; Costanzo, A.; Narcisi, A.

Titolo:

Long-term effectiveness and tolerability of apremilast in patients with moderate-to- severe plaque psoriasis: A 5-year multicentre retrospective study—IL PSO (Italian landscape psoriasis)

Anno:

2024

Tipologia prodotto:

Articolo in Rivista

Tipologia ANVUR:

Articolo su rivista

Lingua:

Inglese

Referee:

No

Nome rivista:

Journal of the European Academy of Dermatology and Venereology

ISSN Rivista:

0926-9959

Intervallo pagine:

946-949

Parole chiave:

Long-term effectiveness and tolerability of apremilast in patients with moderate-to- severe plaque psoriasis

Breve descrizione dei contenuti:

Apremilast is an oral inhibitor of phosphodiesterase (PDE)-4 that has been approved for the treatment of patients with moderate-to- severe plaque psoriasis who have contraindications or inadequate response to conventional systemic treatments. 1,2 It is also indicated for the management of adults with active psoriatic arthritis (PsA) who have failed or are intolerant to other disease-modifying antirheumatic drugs (DMARDs).1,2 In Italy, apremilast is reimbursed for patients with moderate-to- severe plaque psoriasis in case of inadequate response/intolerance to systemic treatments and those with contraindications to biological drugs.3 Despite the wide use of apremilast for the treatment of plaque psoriasis, long-term real-world experiences are still limited.4,5

Id prodotto:

142095

Handle IRIS:

11562/1144247

ultima modifica:

31 ottobre 2024

Citazione bibliografica:

Gargiulo, L.; Ibba, L.; Malagoli, P.; Amoruso, F.; Balato, A.; Bardazzi, F.; Burlando, M.; Carrera, C. G.; Dapavo, P.; Dini, V.; Gaiani, F. M.; Girolomoni, G.; Guarneri, C.; Lasagni, C.; Loconsole, F.; Marzano, A. V.; Maurelli, M.; Megna, M.; Travaglini, M.; Costanzo, A.; Narcisi, A., Long-term effectiveness and tolerability of apremilast in patients with moderate-to- severe plaque psoriasis: A 5-year multicentre retrospective study—IL PSO (Italian landscape psoriasis) «Journal of the European Academy of Dermatology and Venereology» , 2024 , pp. 946-949

Consulta la scheda completa presente nel repository istituzionale della Ricerca di Ateneo